These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 11869941)
1. Selecting patients for home treatment of deep vein thrombosis: the problem of cancer. Ageno W; Steidl L; Marchesi C; Dentali F; Mera V; Squizzato A; Crowther MA; Venco A Haematologica; 2002 Mar; 87(3):286-91. PubMed ID: 11869941 [TBL] [Abstract][Full Text] [Related]
2. Home-treatment of deep vein thrombosis in patients with cancer. Ageno W; Grimwood R; Limbiati S; Dentali F; Steidl L; Wells PS Haematologica; 2005 Feb; 90(2):220-4. PubMed ID: 15710575 [TBL] [Abstract][Full Text] [Related]
3. Eligibility for home treatment of deep vein thrombosis: a prospective study in 202 consecutive patients. Schwarz T; Schmidt B; Beyer J; Schröder HE; Schellong SM J Vasc Surg; 2001 Dec; 34(6):1065-70. PubMed ID: 11743562 [TBL] [Abstract][Full Text] [Related]
4. Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism. Grau E; Tenias JM; Real E; Medrano J; Ferrer R; Pastor E; Selfa S Am J Hematol; 2001 May; 67(1):10-4. PubMed ID: 11279651 [TBL] [Abstract][Full Text] [Related]
5. Home treatment of deep vein thrombosis: a two-years experience of a single institution. Grau E; Real E; Pastor E; Viciano V; Aguiló J Haematologica; 1998 May; 83(5):438-41. PubMed ID: 9658729 [TBL] [Abstract][Full Text] [Related]
7. Out-patient treatment of acute deep vein thrombosis. Mattiasson I; Berntorp E; Bornhov S; Lagerstedt C; Lethagen S; Persson J; Timberg I; Torstensson I Int Angiol; 1998 Sep; 17(3):146-50. PubMed ID: 9821026 [TBL] [Abstract][Full Text] [Related]
8. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression. Labas P; Ohrádka B; Vladimír J; Cambal M Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727 [TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry. Imberti D; Agnelli G; Ageno W; Moia M; Palareti G; Pistelli R; Rossi R; Verso M; Haematologica; 2008 Feb; 93(2):273-8. PubMed ID: 18223291 [TBL] [Abstract][Full Text] [Related]
10. [Short-term and long-term evolution of deep vein thrombosis treated by a health care unit]. Martín-Carbonero L; Salgado X; Pedrajas JM; Armengol JG; Jiménez Rodríguez-Madridejos R; Fernández-Cruz A Rev Clin Esp; 2002 Aug; 202(8):430-4. PubMed ID: 12199992 [TBL] [Abstract][Full Text] [Related]
11. The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy. Rodger MA; Gagné-Rodger C; Howley HE; Carrier M; Coyle D; Wells PS Thromb Res; 2003; 112(1-2):13-8. PubMed ID: 15013267 [TBL] [Abstract][Full Text] [Related]
12. Application of a diagnostic clinical model for the management of hospitalized patients with suspected deep-vein thrombosis. Wells PS; Anderson DR; Bormanis J; Guy F; Mitchell M; Gray L; Clement C; Robinson KS; Lewandowski B Thromb Haemost; 1999 Apr; 81(4):493-7. PubMed ID: 10235426 [TBL] [Abstract][Full Text] [Related]
13. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group. van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572 [TBL] [Abstract][Full Text] [Related]
15. [Hospitalization criteria for erysipelas: prospective study in 145 cases]. Jégou J; Hansmann Y; Chalot F; Roger M; Faivre B; Granel F; Scrivener Y; Cairey-Remonnay S; Bernard P Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 1):375-9. PubMed ID: 12055535 [TBL] [Abstract][Full Text] [Related]
16. Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital. Lee M; Pao D; Hsu T; Sonderskov A Can J Clin Pharmacol; 2004; 11(1):e17-27. PubMed ID: 15226523 [TBL] [Abstract][Full Text] [Related]
17. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity. Savage KJ; Wells PS; Schulz V; Goudie D; Morrow B; Cruickshank M; Kovacs MJ Thromb Haemost; 1999 Sep; 82(3):1008-10. PubMed ID: 10494754 [TBL] [Abstract][Full Text] [Related]
18. Managing cancer patients with acute venous thromboembolism: exploring safe alternatives to hospitalisation. Siragusa S; Anastasio R; Giarratano A; Malato A; Bonifacio G; Arcara C; Gebbia N Exp Oncol; 2004 Sep; 26(3):192-5. PubMed ID: 15494686 [TBL] [Abstract][Full Text] [Related]
19. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation. Huse DM; Cummins G; Taylor DC; Russell MW Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346 [TBL] [Abstract][Full Text] [Related]
20. Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program. Groce JB Pharmacotherapy; 1998; 18(6 Pt 3):175S-180S. PubMed ID: 9853912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]